All registered pharmacies will soon have identifiers for registered premises in a renewed effort to weed out illegal practitioners from the industry.
The pharmaceutical industry regulator has announced new plans in a renewed effort to protect public health and uphold industry standards.
The Pharmacy and Poisons Board chairman Charles Githinji on Thursday unveiled a comprehensive plan to address this pressing issue.
Speaking during the 19th Annual Scientific Conference of the Kenya Pharmaceutical Association, Githinji said the measures aim to combat the presence of illegal practices in the pharmaceutical industry.
“Implementing identifiers for registered premises, geospatial mapping, and a multi-agency approach forms the core of PPB's strategy,” Githinji said.
“These measures aim to enhance regulatory oversight, ensuring a crackdown on illegal practices in the pharmaceutical industry.”
In March, the board began developing guidelines to regulate the activities of pharmaceutical sales representatives in the country.
This is to ensure that pharmaceutical sales representatives are qualified to perform their tasks and act ethically in promoting medicines and other health products and technologies to healthcare professionals.
The Director Pharmacy Practice at PPB Dr Wilfred Ochieng said it is crucial to establish guidelines that govern the qualifications, standards of practice and activities of pharmaceutical sales representatives as the pharmaceutical industry continues to grow in Kenya.
This, he said, will also ensure the promotion of medicines in Kenya is done within the legal framework and that the information shared with healthcare workers remains factual, evidence-based and not misleading.
